NEXTBIOMEDICAL Co., Ltd.
Founded in 2014 and listed on KOSDAQ in 2024, NEXTBIOMEDICAL develops endoscopic hemostats and vascular embolization microspheres.
As of 2026-10-08, NEXTBIOMEDICAL Co., Ltd. has 24 Korean MFDS device approvals, 2 US FDA clearances/approvals, 2 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Regulatory approvals
data.go.kr · openFDA24 Korean MFDS device approvals · 2015–2025 / 2 US FDA 510(k) · 2022–2024
- MFDSEmbolization implant inserter, intervascular2025-11-19Product approval · Class 3제허 25-781 호
- MFDSEmbolization implant inserter, intervascular2025-07-28Product approval · Class 3제허 25-515 호
- FDANexpowder2024-11-27
- MFDSDressing, absorbable, wound, synthetic polymer2024-11-26Product approval · Class 4제허 24-837 호
- FDANexpowder2022-09-16
- MFDSDressing, absorbable, wound, synthetic polymer2021-12-08Product approval · Class 4제허 21-990 호
- MFDSEmbolization implant inserter, intervascularRevoked2020-12-10Product approval · Class 3제허 20-1064 호
- MFDSStent, duodenalRevoked2020-10-15Product approval · Class 3제허 20-887 호
- MFDSStent, colonRevoked2020-10-15Product approval · Class 3제허 20-886 호
- MFDSEmbolization implant inserter, intervascular2019-06-27Product approval · Class 3제허 19-412 호
- MFDSStent, colonRevoked2018-04-05Product approval · Class 3제허 18-229 호
- MFDSOesophageal stentRevoked2018-04-05Product approval · Class 3제허 18-228 호
Show 14 more
- MFDSStent, duodenalRevoked2018-04-02Product approval · Class 3제허 18-216 호
- MFDSBiliary stentRevoked2018-04-02Product approval · Class 3제허 18-215 호
- MFDSStent, duodenalRevoked2018-03-14Product approval · Class 3제허 18-174 호
- MFDSEndotherapy cannula, single-use2018-02-23Product approval · Class 2제인 18-4140 호
- MFDSDressing, absorbable, wound, synthetic polymer2018-01-09Product approval · Class 4제허 18-14 호
- MFDSStent, colonRevoked2016-07-04Product approval · Class 3제허 16-470 호
- MFDSStent, colonRevoked2016-07-04Product approval · Class 3제허 16-469 호
- MFDSStent, duodenalRevoked2016-06-21Product approval · Class 3제허 16-438 호
- MFDSBiliary stentRevoked2016-02-25Product approval · Class 3제허 16-144 호
- MFDSOesophageal stentRevoked2016-02-18Product approval · Class 3제허 16-123 호
- MFDSENT powder applicatorRevoked2016-02-11Product approval · Class 1수신 16-370 호
- MFDSENT powder applicator2015-11-10Product approval · Class 1제신 15-380 호
- MFDSBiliary stentRevoked2015-11-02Product approval · Class 3제허 15-1539 호
- MFDSOesophageal stentRevoked2015-11-02Product approval · Class 3제허 15-1540 호
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Wearable OLED-Assisted Photodynamic Cancer Therapy Using Chlorin e6-Loaded Pluronic Nanocapsules as Photosensitizers.
Advanced healthcare materials · 2026-09 · Oh H, Jeong SM, Park CH 외 5
- Self-Assembled PLGA-Pluronic F127 Microsphere for Sustained Drug Release for Osteoarthritis.
Pharmaceuticals (Basel, Switzerland) · 2024-04 · Seon S, Li Y, Lee S 외 3
Patents
KIPRIS · applicant-matchedPublished · 2025-10 · Application 1020250146270
EP · Published · 2023-11 · Application 25216196.3
EP · Registered · 2023-11 · Application 23207251.2
CN · Published · 2023-10 · Application 202311421527.7
US · Published · 2023-09 · Application 18242640
Registered · 2023-03 · Application 1020230028780
Abandoned · 2022-12 · Application 1020220190482
CN · Published · 2022-04 · Application 202280030578.4
US · Registered · 2022-04 · Application 18286725
EP · Published · 2022-04 · Application 22796192.7
Show 31 more patents
PCT · Published · 2022-04 · Application PCT/KR2022/006131
Registered · 2021-04 · Application 1020210055086
Registered · 2020-12 · Application 1020200174822
Rejected · 2020-11 · Application 1020200147139
PCT · Published · 2020-11 · Application PCT/KR2020/015380
CN · Published · 2019-11 · Application 201980079960.2
US · Registered · 2019-11 · Application 17297254
EP · Registered · 2019-11 · Application 19891265.1
PCT · Published · 2019-11 · Application PCT/KR2019/016792
Registered · 2019-11 · Application 1020190157703
Withdrawn · 2019-11 · Application 1020190140548
Expired · 2018-10 · Application 1020180130129
Expired · 2018-05 · Application 1020180057834
Expired · 2018-05 · Application 1020180057835
US · Published · 2017-10 · Application 16345109
EP · Published · 2017-10 · Application 17865214.5
PCT · Published · 2017-10 · Application PCT/KR2017/012057
Expired · 2016-10 · Application 1020160142423
CN · Published · 2016-03 · Application 201680004866.7
US · Registered · 2016-03 · Application 15545058
Expired · 2016-03 · Application 1020160028399
EP · Published · 2016-03 · Application 16761983.2
PCT · Published · 2016-03 · Application PCT/KR2016/002352
Expired · 2016-02 · Application 1020160023467
Expired · 2016-02 · Application 1020160023466
Expired · 2015-12 · Application 1020150172127
Expired · 2015-12 · Application 1020150172134
Expired · 2015-10 · Application 1020150148553
US · Registered · 2015-09 · Application 15510044
EP · Registered · 2015-09 · Application 15843103.1
EP · Registered · 2015-01 · Application 15740074.8
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot34
- PerplexityPerplexityBot2
- GoogleGoogleOther2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 7, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for NEXTBIOMEDICAL Co., Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.
Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.
Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.
Spun off from Jeil Pharm Holdings in 2017, Jeil Pharmaceutical has licensed out its GERD drug Zastaprazan (Jaqubo) to multiple overseas partners.
Interojo, founded 2000 and KOSDAQ-listed 2010, manufactures contact lenses under its Clalen brand domestically and via OEM/ODM overseas.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
Founded in 2012 and listed on KOSDAQ in 2026, REMEDI develops portable X-ray imaging devices based on its low-dose, miniaturized X-ray technology.
KOSDAQ-listed medical device company developing the LOTUS and HELIOS laser aesthetic devices and the PALLAS vitiligo treatment device.
Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition